VIMFLUITY Trademark

Trademark Overview


On Friday, September 23, 2022, a trademark application was filed for VIMFLUITY with the United States Patent and Trademark Office. The USPTO has given the VIMFLUITY trademark a serial number of 97604606. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by Pfizer Inc.. The VIMFLUITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
vimfluity

General Information


Serial Number97604606
Word MarkVIMFLUITY
Filing DateFriday, September 23, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Trademark Events


Event DateEvent Description
Tuesday, September 27, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 28, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 7, 2023ASSIGNED TO EXAMINER
Tuesday, July 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 11, 2023NON-FINAL ACTION E-MAILED
Tuesday, July 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 21, 2023NON-FINAL ACTION WRITTEN
Thursday, September 21, 2023NON-FINAL ACTION E-MAILED
Thursday, September 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 1 FILED
Wednesday, July 31, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT